LLLR与OLLR治疗左外叶肝细胞癌临床效果及远期生存率比较

doi:10.3969/j.issn.1672-5069.2017.04.018

摘要/Abstract

摘要： 目的比较腹腔镜左肝外切除术（LLLR）与开腹左肝外切除术（OLLR）治疗左外叶肝细胞癌（HCC）患者的临床效果及生存期。方法我院2011年4月~2013年6月收治的左外叶HCC患者94例,采用随机数字表法将其分为对照组47例和观察组47例,分别接受OLLR和LLLR治疗。比较两组患者手术指标及并发症发生情况。采用ELISA法检测血清细胞间黏附分子（ICAM）-1、基质金属蛋白酶（MMP）-13和IL-6,常规检测血清炎症因子和免疫球蛋白水平变化。术后随访3年,比较两组患者术后1 a、2 a和3 a生存率。结果观察组术中出血量为（134.94±23.51） ml,显著低于对照组[（290.18±30.76） ml,P<0.01],首次进食时间为（2.29±0.51） d,显著短于对照组[（3.80±0.87） d,P<0.01],住院时间为（7.43±2.39） d,显著短于对照组[（11.42±3.08） d,P<0.01];手术后,观察组血清ICAM-1为（8.08±2.13） ng/ml,显著低于对照组[（13.27±2.60） ng/ml,P<0.01],MMP-13为（113.65±21.92） ng/ml,显著低于对照组[（171.02±27.85） ng/ml,P<0.01],降钙素原（PCT）为（7.23±0.74） μg/L,显著低于对照组[（11.24±1.53） μg/L,P<0.01],IL-6为（11.49±2.78） pg/L,显著低于对照组[（19.06±3.27） pg/L,P<0.01],IgA为（2.63±0.46） g/L,显著高于对照组[（1.49±0.41） g/L,P<0.01],IgM为（1.92±0.33） g/L,显著高于对照组[（1.40±0.27） g/L,P<0.01],IgG为（9.72±1.53） g/L,显著高于对照组[（6.40±0.85） g/L,P<0.01];观察组并发症发生率（12.8%）明显低于对照组（42.5%,P<0.05）;两组患者术后1 a、2 a和3 a生存率比较,均无明显差异（P>0.05）。结论 LLLR能明显降低左外叶HCC患者的手术创伤,减少术后并发症,而对患者生存率无明显影响。

关键词: 肝细胞癌, 腹腔镜左肝外切除术, 开腹左肝外切除术, 并发症, 生存率

Abstract: Objective To compare laparoscopic left hepatic resection（LLLR） and laparoscopic left hepatic resection （OLLR） in treatment of patients with left lateral lobe hepatocellular carcinoma （HCC）. Methods 94 patients with left lateral HCC in our hospital between April 2011 and June 2013 were recruited in this study,and they were randomly divided into control and observation group,with 47 cases in each group. The patients in control group received OLLR,and those in observation group were treated with LLLR. Serum ICAM-1,MMP-13 and IL-6 levels were detected by ELISA. All patients were followed-up for 3 years,and the survival rates at 1 year,2 years and 3 years after operation were recorded. Results The amount of bleeding in the observation group was （134.94±23.51） ml,significantly lower than in the control group [（290.18±30.76） ml,P<0.01],eating after operation was（2.29±0.51） d,significantly shorter than in the control group[（3.80±0.87） d,P<0.01], hospitalization stay was（7.43±2.39） d,significantly shorter than in the control group [（11.42±3.08） d,P<0.01]; serum ICAM-1 levels after operation in observation group was （8.08±2.13） ng/ml,significantly lower than in the control group [（3.27±2.60） ng/ml,P<0.01],MMP-13 was（113.65±21.92） ng/ml,significantly lower than in the control group [（171.02±27.85） ng/ml,P<0.01], PCT was （7.23±0.74） g/L,significantly lower than in the control group [（11.24±1.53） g/L,P<0.01],IL-6 was （11.49±2.78） pg/L, significantly lower than in the control group [（19.06±3.27） pg/L,P<0.01];serum IgA,IgM and IgG levels were significantly higher than in the control group （P<0.01）;the incidence of complica-tions in the observation group （12.8%） was signifi-cantly lower than in the control group （42.5%,P<0.05）;there was no significant difference as respect to the survival rates between the two groups in three year follow-up. Conclusion LLLR is an alternative approaches in the treatment of patients with left lateral lobe HCC,as it could significantly reduce the postoperative complications,inflammatory reactions and protect the immune functions with the similar long-term efficacy.

Key words: Hepatoma, Laparoscopic left hepatic resection, Laparoscopic left hepatic resection, Complication, Survival rate

伍强, 李光耀, 皮儒先, 王伟, 陈平. LLLR与OLLR治疗左外叶肝细胞癌临床效果及远期生存率比较[J]. 实用肝脏病杂志, 2017, 20(4): 451-454.

Wu Qiang, Li Guangyao, Pi Ruxian, et al.. Comparison of clinical efficacy and long-term survival in patients with hepatocellular carcinoma receiving LLLR and OLLR[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 451-454.

参考文献

[1] 张健,邵初晓. 原发性肝癌早期诊断的研究进展. 中华肝胆外科杂志,2014,20（9）:689-693.
[2] Geller DA. Laparoscopic or SILS liver resection for hepatic left lateral sectionectomy? World J Surg,2014,38（10）:2674-2675.
[3] 胡建新,刘秀颀,李德民,等. 肝癌门静脉癌栓影像学分型与临床病理分型的对比研究. 河北医药,2015,21（1）:88-89.
[4] Ker CG,Chen HY,Chen HJ,et al. Challenge of safety margin in laparoscopic liver resection for hepatocellular carcinoma. Formosan J Surg,2014,47（5）:183-188.
[5] 魏志力,耿智敏. 腹腔镜手术与传统手术治疗胆管结石临床疗效对比研究. 实用肝脏病杂志,2016,19（3）:339-342.
[6] 韩亚飞,邰沁文,温浩,等. 腹腔镜与开腹肝左外叶切除术的比较. 中国微创外科杂志,2013,13（5）:403-405.
[7] Kanazawa A,Tsukamoto T,Shimizu S,et al. Laparoscopic liver resection for treating recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Sci,2013,20（5）:512-517.
[8] 田虎,张阳德. 腹腔镜辅助射频消融与经皮射频消融治疗原发性肝癌的临床对照研究. 中华普通外科杂志,2012,27（7）:564-567.
[9] Zhang Y,Chen X M,Sun D L. Comparison of laparoscopic versus open left lateral segmentectomy. Int J Clin Exp Med,2015,8（1）:904-909.
[10] 许秋然,郑鑫,姚英民,等. 肝移植术与肝切除术治疗原发性肝癌的meta分析. 西安交通大学学报（医学版）,2012,33（5）:576-582.
[11] Virgilio E,Scorsi A,Amodio PM,et al. Port site recurrences following laparoscopic liver resection for hepatocellular carcinoma. World J Surg,2016,40（7）:1-2.
[12] Dokmak S,Raut V,Aussilhou B,et al. Laparoscopic left lateral resection is the gold standard for benign liver lesions: a case-control study. Hpb,2014,16（2）:183-187.
[13] 佟庆,丁伟,晏冬,等. 腹腔镜与开腹肝切除术治疗肝癌疗效的Meta分析. 中国普通外科杂志,2015,24（1）:27-33.
[14] Cheung TT,Poon RT,Dai WC,et al. Pure laparoscopic versus open left lateral sectionectomy for hepatocellular carcinoma:asingle-center experience. World J Surg,2016,40（1）:1-8.
[15] 向伦建,李建伟,陈健,等. 腹腔镜肝切除术治疗84例大肝癌的临床疗效.中华消化外科杂志,2014,13（6）:464-467.
[16] Li W,Zhou X,Huang Z,et al. Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma. Surg Endosc,2015,29（11）:3146-3153.
[17] 徐军辉,丁佑铭,汪斌,等. 腹腔镜肝切除术在肝癌合并肝硬化患者中的应用. 临床肝胆病杂志,2014,30（6）:552-555.
[18] Geller DA,Tsung A. Longterm outcomes and safety of laparoscopic liver resection surgery for hepatocellular carcinoma and metastatic colorectal cancer. J Hepatobiliary Pancreat Sci,2015,22（10）:728-730.
[19] Memeo R,De’Angelis N,Compagnon P,et al. Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver:a case-control study. World J Surg,2014,38（11）:2919-2927.
[20] 朱建云,张建忠,黄书明,等. MMP-13和TIMP-1在良恶性肝病患者血清、肝组织中的表达及临床意义. 临床检验杂志,2012,30（6）:433-435.